Hypothalamic clamp on insulin release by leptin-transgene expression

Peptides

Volumn 27, Issue 12, 2006, Pages 3245-3254

  Boghossian, Stéphane ^a   Dube, Michael G ^b   Torto, Rita ^b   Kalra, Pushpa S ^b   Kalra, Satya P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Department of Physiology and Functional Genomics ^*  (United States)

Author keywords

Hypothalamus; Insulin release; Insulin resistance; Leptin gene therapy

Indexed keywords

INSULIN; LEPTIN; RECOMBINANT LEPTIN;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE TOLERANCE; HYPERINSULINEMIA; HYPOINSULINEMIA; HYPOTHALAMUS; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS SECRETION; PARVOVIRUS VECTOR; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; TRANSGENE; WEIGHT GAIN;

ANIMALS; FEMALE; GENE TRANSFER TECHNIQUES; HYPOTHALAMUS; INSULIN; LEPTIN; MALE; MICE; MICE, TRANSGENIC; RATS; RATS, SPRAGUE-DAWLEY;

ADENO-ASSOCIATED VIRUS;

EID: 33750948987     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.07.022     Document Type: Article

References (60)

1. Ahima R.S., Bjorbaek C., Osei S., and Flier J.S. Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology 140 (1999) 2755-2762
2. Ahima R.S., and Flier J.S. Leptin. Annu Rev Physiol 62 (2000) 413-437
3. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J.P., Bortoluzzi M.N., et al. The stomach is a source of leptin. Nature 394 (1998) 790-793
4. Bagnasco M., Dube M.G., Kalra P.S., and Kalra S.P. Evidence for the existence of distinct central appetite and energy expenditure pathways and stimulation of ghrelin as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 143 (2002) 4409-4421
5. Bagnasco M., Dube M.G., Katz A., Kalra P.S., and Kalra S.P. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obesity Res 11 (2003) 1463-1470
6. Banks W.A., DiPalma C.R., and Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20 (1999) 1341-1345
7. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., and Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 17 (1996) 305-311
8. Baratta M. Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit 8 (2002) RA282-RA292
9. Beretta E., Dube M.G., Kalra P.S., and Kalra S.P. Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes. Pediatr Res 52 (2002) 189-198
10. Boghossian S., Lecklin A.H., Torto R., Kalra P.S., and Kalra S.P. Suppression of fat deposition for the life time of rodents with gene therapy. Peptides 26 (2005) 1512-1519
11. Bray G.A. Medical consequences of obesity. J Clin Endocrinol Metab 89 (2004) 2583-2589
12. Buijs R.M., Chun S.J., Niijima A., Romijn H.J., and Nagai K. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J Comp Neurol 431 (2001) 405-423
13. Burguera B., Couce M.E., Curran G.L., Jensen M.D., Lloyd R.V., Cleary M.P., et al. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49 (2000) 1219-1223
14. Casabiell X., Pineiro V., De la Cruz L.F., Gualillo O., Folgar L., Dieguez C., et al. Dual effect of insulin on in vitro leptin secretion by adipose tissue. Biochem Biophys Res Commun 276 (2000) 477-482
15. Cases J.A., Gabriely I., Ma X.H., Yang X.M., Michaeli T., Fleischer N., et al. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 50 (2001) 348-352
16. Chehab F.F. Leptin as a regulator of adipose mass and reproduction. Trends Pharmacol Sci 21 (2000) 309-314
17. Chen G., Koyama K., Yuan X., Lee Y., Zhou Y.T., O'Doherty R., et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 93 (1996) 14795-14799
18. Chen Y., and Heiman M.L. Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats. Regul Pept 92 (2000) 113-119
19. Chinookoswong N., Wang J.L., and Shi Z.Q. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 48 (1999) 1487-1492
20. Cohen P., Zhao C., Cai X., Montez J.M., Rohani S.C., Feinstein P., et al. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108 (2001) 1113-1121
21. de Luca C., Kowalski T.J., Zhang Y., Elmquist J.K., Lee C., Kilimann M.W., et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest 115 (2005) 3484-3493
22. Della-Fera M.A., Choi Y.H., Hartzell D.L., Duan J., Hamrick M., and Baile C.A. Sensitivity of ob/ob mice to leptin-induced adipose tissue apoptosis. Obes Res 13 (2005) 1540-1547
23. Dhillon H. Effects of recombinant adeno-associated virus encoding leptin on body weight regulation and energy homeostasis. University of Florida, http://etd.fcla.edu/uf/ane5948/dissertation.pdf; 2000.
24. Dhillon H., Ge Y., Minter R.M., Prima V., Moldawer L.L., Muzyczka N., et al. Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice Relationship with body weight change. Regul Pept 92 (2000) 97-105
25. Dhillon H., Kalra S.P., and Kalra P.S. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther 4 (2001) 139-145
26. Dube M.G., Beretta E., Dhillon H., Ueno N., Kalra P.S., and Kalra S.P. Central leptin gene therapy blocks high fat diet-induced weight gain, hyperleptinemia and hyperinsulinemia: effects on serum ghrelin levels. Diabetes 51 (2002) 1729-1736
27. Farooqi I.S., Jebb S.A., Langmack G., Lawrence E., Cheetham C.H., Prentice A.M., et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341 (1999) 879-884
28. Friedman J.M. The function of leptin in nutrition, weight, and physiology. Nutr Rev 60 S1-S14 (2002) S68-S87
29. Fruhbeck G. Peripheral actions of leptin and its involvement in disease. Nutr Rev 60 S47-S55 (2002) S68-S87
30. Gullicksen P.S., Hausman D.B., Dean R.G., Hartzell D.L., and Baile C.A. Adipose tissue cellularity and apoptosis after intracerebroventricular injections of leptin and 21 days of recovery in rats. Int J Obes Relat Metab Disord 27 (2003) 302-312
31. Hidaka S., Yoshimatsu H., Kondou S., Tsuruta Y., Oka K., Noguchi H., et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J 16 (2002) 509-518
32. Horvath T.L., Diano S., and Tschop M. Brain circuits regulating energy homeostasis. Neuroscientist 10 (2004) 235-246
33. Jazet I.M., Pijl H., and Meinders A.E. Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 61 (2003) 194-212
34. Kalra S.P., Bagnasco M., Otukonyong E.E., Dube M.G., and Kalra P.S. Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity. Regul Pept 111 (2003) 1-11
35. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., and Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrinol Rev 20 (1999) 68-100
36. Kalra S.P., and Kalra P.S. Gene transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life-expectancy. Trends Pharmacol Sci 26 (2005) 488-495
37. Kalra S.P., and Kalra P.S. Keeping obesity and metabolic syndrome at bay with central leptin and cytokine gene therapy. In: Hamilton I. (Ed). Current medicinal chemistry-central nervous system agent (2003), Bentham Science Publishers Ltd., San Francisco, CA 189-199
38. Karsenty G. Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res 56 (2001) 401-415
39. Kieffer T.J., and Habener J.F. The adipoinsular axis: effects of leptin on pancreatic B-cells. Am J Physiol Endocrinol Metab 278 (2000) E1-E14
40. Koyama K., Shimabukuro M., Chen G., Wang M.Y., Lee Y., Kalra P.S., et al. Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors. J Clin Invest 102 (1998) 728-733
41. Lazar M.A. How obesity causes diabetes: not a tall tale. Science 307 (2005) 373-375
42. Lecklin A.H., Dube M.G., Torto R., Kalra P.S., and Kalra S.P. Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation. Peptides 26 (2005) 1176-1187
43. Lewis G.F., Carpentier A., Adeli K., and Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrinol Rev 23 (2002) 201-229
44. Lord G. Role of leptin in immunology. Nutr Rev 60 S35-S38 (2002) S68-S87
45. Luiten P.G., ter Horst G.J., and Steffens A.B. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol 28 (1987) 1-54
46. Maness L.M., Kastin A.J., Farrell C.L., and Banks W.A. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 139 (1998) 4556-4562
47. Otukonyong E.E., Dube M.G., Torto R., Kalra P.S., and Kalra S.P. Central leptin differentially modulates ultradian secretory patterns of insulin, leptin and ghrelin independent of effects on food intake and body weight. Peptides 26 (2005) 2559-2566
48. Otukonyong E.E., Dube M.G., Torto R., Kalra P.S., and Kalra S.P. High fat diet-induced ultradian leptin and insulin hypersecretion and ghrelin is absent in obesity-resistant rats. Obesity Res I13 (2005) 991-999
49. Porte D.J., Baskin D.G., and Schwartz M.W. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54 (2004) 1264-1276
50. Pu S., Dube M.G., Kalra P.S., and Kalra S.P. Regulation of leptin secretion: effects of aging on daily patterns of serum leptin and food consumption. Regul Pept 92 (2000) 107-111
51. Sahu A. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. J Neuroendocrinol 14 (2002) 796-804
52. Seufert J., Kieffer T.J., and Habener J.F. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 96 (1999) 674-679
53. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
54. Steppann C.M., and Swick A.G. A role for leptin in brain development. Biochem Biophys Res Commun 256 (1999) 600-602
55. Ueno N., Dube M.G., Inui A., Kalra P.S., and Kalra S.P. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 145 (2004) 4176-4184
56. Ueno N., Inui A., Kalra S.P., and Kalra P.S. Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides 27 (2006) 2332-2342
57. Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
58. Wang J., Takeuchi T., Tanaka S., Kubo S.K., Kayo T., Lu D., et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103 (1999) 27-37
59. Wilkinson M., Morash B., and Ur E. The Brain is a source of leptin. Front Horm Res 26 (2000) 106-125
60. Xu B., Kalra P.S., Farmerie W.G., and Kalra S.P. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology 140 (1999) 2868-2875